Autoimmune Diseases: all 672 studies
Page 2 of 7. Open to participants first (272), then studies with results posted, then the rest; newest registration first within each.
- Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune ThrombocytopeniaRecruitingNCT06973356Not applicable
- Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06970951Early Phase 1
- Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune DiseaseRecruitingNCT06964269Phase 4
- A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06948318Phase 3
- Deciphering the Genetic Architecture of Autoimmune DiseasesRecruitingNCT06948110
- Network to Understand Reproductive Rheumatology RegistryEnrolling by invitationNCT06940869
- Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum DisorderRecruitingNCT06934915Early Phase 1
- The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen PlanusRecruitingNCT06932848Not applicable
- Mesenchymal Stem Cells Infusion in Patients With Autoimmune DiseasesEnrolling by invitationNCT06888973Phase 1/2
- JY231(JY231) Injection for the Treatment of Refractory Autoimmune Diseases (ADs)Not yet recruitingNCT06887985Not applicable
- Research of Predictive Factors of in Vitro Fertilization (IVF) Outcome AI-IVF StudyRecruitingNCT06872294
- Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.RecruitingNCT06858319Phase 3
- Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia GravisNot yet recruitingNCT06827587Not applicable
- Acute Metabolic Effects of Tirzepatide in Type 1 DiabetesRecruitingNCT06820281Phase 2
- Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised IndividualsRecruitingNCT06817889Phase 2
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT06794008Phase 2
- Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune DiseaseRecruitingNCT06792799Early Phase 1
- Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)RecruitingNCT06779799
- A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune DiseasesNot yet recruitingNCT06774664Phase 1/2
- A Study of CAR-T Cells in Subjects with Autoimmune DiseasesNot yet recruitingNCT06762119Early Phase 1
- Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune DiseasesNot yet recruitingNCT06757426
- Prophylactic Tranexamic Acid Reduces Postpartum HemorrhageRecruitingNCT06754371Phase 4
- A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune DiseasesRecruitingNCT06747156Early Phase 1
- Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy VolunteersRecruitingNCT06736587Phase 1
- Telitacicept and Low-dose Steroids in Refractory Myasthenia GravisNot yet recruitingNCT06723548Phase 4
- A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 3
- US Zamto-cel Autoimmune DiseasesRecruitingNCT06708845Phase 1
- Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune DiseasesRecruitingNCT06688799Phase 1/2
- Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune DiseasesRecruitingNCT06685042Phase 1/2
- CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06680388Early Phase 1
- The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSDNot yet recruitingNCT06633042Phase 1
- Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related DiseasesRecruitingNCT06626919Phase 1
- Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)RecruitingNCT06591260
- Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.RecruitingNCT06581562Phase 1
- A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusRecruitingNCT06575426Phase 1/2
- A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue DiseaseRecruitingNCT06572384Phase 3
- JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune DiseasesNot yet recruitingNCT06567080Phase 1
- Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRURecruitingNCT06551389
- Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune DiseasesRecruitingNCT06548607Early Phase 1
- Digital Diagnostics and Intervention Services for Parkinson's DiseaseNot yet recruitingNCT06534177
- Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada?Not yet recruitingNCT06507800
- An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune DiseasesRecruitingNCT06503224Not applicable
- Biomarkers in Autoimmune Disease of Nervous SystemRecruitingNCT06502015
- Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic DiseaseRecruitingNCT06499233Phase 4
- Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.Not yet recruitingNCT06485232Early Phase 1
- Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus ErythematosusEnrolling by invitationNCT06475742Phase 3
- Testimonials and Navigation in RheumatologyRecruitingNCT06469788Not applicable
- An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06464679Phase 1
- Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T CellsNot yet recruitingNCT06435897Phase 1/2
- Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory DiseasesRecruitingNCT06435468Not applicable
- Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune DisordersRecruitingNCT06434363Phase 1/2
- Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune DiseasesRecruitingNCT06428188Phase 1/2
- The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.RecruitingNCT06426316Not applicable
- The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06420154Early Phase 1
- Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID RegistryRecruitingNCT06417502
- Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06417398Early Phase 1
- Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)Not yet recruitingNCT06416267
- Clinical Performance of the New Plasma Filter PX2 in TPE TreatmentsRecruitingNCT06382675Not applicable
- A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune DiseaseEnrolling by invitationNCT06375993Phase 1
- Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune DiseaseRecruitingNCT06373081Not applicable
- ASIA-Mesh: a Pilot Study for Diagnostics and Treatment on ASIA Syndrome Caused by Polypropylene Mesh ImplantationRecruitingNCT06363903
- RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia GravisRecruitingNCT06359041Phase 1/2
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/2
- Rheumatology Diet StudyRecruitingNCT06339957
- RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic SclerosisRecruitingNCT06328777Phase 2/3
- A Clinical Study of CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune DiseasesRecruitingNCT06318533Early Phase 1
- Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune DiseasesRecruitingNCT06316791Early Phase 1
- Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune DiseasesRecruitingNCT06316076Phase 1
- INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World UseRecruitingNCT06314282
- A Phase 1 Study of FT819 in B-cell Mediated Autoimmune DiseaseRecruitingNCT06308978Phase 1
- Systemic Treatments for Alopecia Areata RegistryRecruitingNCT06283316
- CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune DiseasesRecruitingNCT06279923Early Phase 1
- X-linked Moesin Associated ImmunodeficiencyRecruitingNCT06278337
- Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 DiabetesRecruitingNCT06273631Not applicable
- SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATIONRecruitingNCT06248957
- JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune DiseasesNot yet recruitingNCT06243159Early Phase 1
- Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological DysfunctionsRecruitingNCT06235580
- F01 in the Treatment of Autoimmune DiseasesRecruitingNCT06208280Phase 1
- Study of Single Doses of SBT777101 in Subjects With Rheumatoid ArthritisRecruitingNCT06201416Phase 1
- KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia GravisRecruitingNCT06193889Phase 2/3
- Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune DiseasesRecruitingNCT06169865
- RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyRecruitingNCT06154252Phase 2/3
- A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple SclerosisRecruitingNCT06138132Phase 1
- RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus ErythematosusRecruitingNCT06121297Phase 1/2
- Implementation of Support in the Care of Adults Living With Type 1 DiabetesRecruitingNCT06069583Not applicable
- Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune DiseaseRecruitingNCT06056921Phase 1
- A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsRecruitingNCT06056297Phase 3
- The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune DiseasesRecruitingNCT06054373
- Autoimmune and Autoinflammatory Genetics StudyRecruitingNCT06004349
- Clonal Hematopoiesis of Immunological SignificanceNot yet recruitingNCT05969821
- Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying DiseasesNot yet recruitingNCT05965843
- Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant WomenRecruitingNCT05958446
- The Role of Autoimmunity and Obesity in Polycystic Ovary SyndromeNot yet recruitingNCT05929950
- Role of LILRA3 in Ankylosing Spondylitis and Axial Psoriatic PatientsNot yet recruitingNCT05915676
- Gfree - For Improved Blood Sugar and Reduced Inflammation.RecruitingNCT05894746Not applicable
- Evaluate the Safety and Tolerability of SCT650C in Healthy VolunteersNot yet recruitingNCT05894707Phase 1
- AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)Enrolling by invitationNCT05889806
- IMPACT - AndHealth Autoimmune Research RegistryRecruitingNCT05883371
- Ovarian Tissue Cryopreservation for Fertility PreservationRecruitingNCT05875155
- Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesEnrolling by invitationNCT05859997Not applicable